trending Market Intelligence /marketintelligence/en/news-insights/trending/zdfnvrc6yai3trgx6epwfa2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Bellus Health prices C$35M overnight marketed equity offering


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


COVID-19 Impact & Recovery: Investment Banking

Bellus Health prices C$35M overnight marketed equity offering

Bellus Health Inc. priced its overnight marketed equity offering at 95 Canadian cents per share, with initial demand attracting C$35 million for its common shares.

The Laval, Quebec-based biopharmaceutical company will conduct the offering in Canada and potentially in the U.S.

Net proceeds from the offering will be used to fund research and development activities, including the clinical development of the company's lead drug candidate BLU-5937, which treats chronic cough patients who are unresponsive to current therapies. A portion of the proceeds will also go to general and administrative expenses, working capital needs and other general corporate purposes.

The offering is set to close on or about Dec. 18, subject to customary closing conditions.

Bloom Burton Securities Inc. is acting as lead agent on behalf of a syndicate of agents, including Mackie Research Capital Corp.